Drugs / plyethylene glycol 400
last change Apr 2007 re-read 2 minutes ago

plyethylene glycol 400

Developed for
dry eye syndrome
Investigated by
Abbott Medical Optics

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00607776 Jan → Apr 2007 dry eye syndrome Abbott Medical Optics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as plyethylene glycol 400 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00607776